| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-16 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-11 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.31 | 4e-09 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-09 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.25 | 3e-07 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |